Arturo Serrano-Batista

Title: The Innovations of Arturo Serrano-Batista

Introduction

Arturo Serrano-Batista is an accomplished inventor based in Sloatsburg, NY (US). He has made significant contributions to the field of immunology through his innovative work on immunomodulatory imide compounds. His research focuses on developing stable solutions for parenteral use, which can have a profound impact on treating immune-mediated inflammatory diseases.

Latest Patents

Arturo holds a patent for "Stable solutions of immunomodulatory imide compounds for parenteral use." This patent provides compositions comprising a stable solution of an immune-mediated inflammatory disease (IMID) agent, such as an immunomodulatory imide drug (IMiD) including lenalidomide (LLD). The patent details methods of preparing stable solutions of IMiDs and outlines their potential applications in treating inflammatory disorders and cancers through parenteral administration.

Career Highlights

Arturo is currently associated with Starton Therapeutics, Inc., where he continues to advance his research in immunology. His work is pivotal in developing therapies that can improve patient outcomes in various inflammatory conditions. With a focus on innovation, he has successfully secured one patent that showcases his expertise and dedication to the field.

Collaborations

Arturo collaborates with notable professionals in his field, including Rod L Hartwig and James C Oliver. These partnerships enhance the research and development efforts at Starton Therapeutics, Inc., fostering an environment of innovation and progress.

Conclusion

Arturo Serrano-Batista's contributions to the field of immunology through his patent and work at Starton Therapeutics, Inc. highlight his commitment to advancing medical science. His innovative solutions have the potential to significantly impact the treatment of inflammatory diseases and cancers.